Publication|Videos|June 6, 2024
Honeywell and the Future of Life Sciences Manufacturing
Author(s)Honeywell
Shawn Opatka, Vice President & General Manager of Life Sciences at Honeywell, discusses how the company stands out in an industry that constantly evolves.
To learn more about manufacturing in the life sciences industry, Pharmaceutical Technology sat down with Shawn Opatka, Vice President & General Manager of Life Sciences at Honeywell, at a recent INTERPHEX conference to discuss:
- How automation technologies will likely evolve;
- How Honeywell helps meet current industry challenges while maintaining an eye on the future;
- What differentiates Honeywell from the competition in its approach to manufacturing and digitalization.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
3
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
4
European Parliament Revamps Pharmaceutical Policy Framework
5
